Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kalinka23
    Junior Member
    • Aug 2011
    • 7

    #1

    SNP positions in dbSNP and Cosmic databases

    Hi,

    i am doing some SNP calling and i would like to know if the called SNPs are present in the dbSNP and / or in the Cosmic databases. Therefore i have to look at the positions of the called SNPs and then at the positions given in the databases.

    But i don't understand exactly how to interprete the database columns. In both, there are two given positions of the variation: here we have for example the first 5 columns of two different dbSNP entries:
    585 chr1 10326 10327 rs112750067
    585 chr1 10433 10433 rs56289060

    and here, the positions of two different Cosmic database entries:
    Mutation GRCh37 genome position: 17:7578276-7578277
    Mutation GRCh37 genome position: 17:7578433-7578433

    When only one position is given then its clear for me (like 10433 10433 or 17:7578433-7578433). But i don't know which position corresponds to the exact position of the SNP in entries with positions like 10326 10327 (the first dbSNP example) or 17:7578276-7578277 (the first cosmic example). Which one of the two positions corresponds to the exact position of the given SNP?

    Thank you for any help,

    best regards, Karin
  • Milan Radovich
    Junior Member
    • Oct 2009
    • 8

    #2
    Ill speak for dbSNP only, but those entires that have multiple positions like your example "10326 10327" are indels, where those SNPs that have positions like "10433 10433" are SNPs. dbSNP has both SNPs and indels as does COSMIC. One good software to use to annotate your SNPs is ANNOVAR.

    Comment

    • krobison
      Senior Member
      • Nov 2007
      • 734

      #3
      In theory, COSMIC has virtually no SNPs -- it is intended to be somatic mutations only (SNVs). However, some SNPs may have sneaked in due to some tumor samples not having paired germline samples.

      Comment

      • kalinka23
        Junior Member
        • Aug 2011
        • 7

        #4
        Thank you very much Milan and krobinson,

        i had a look at the annotation af ANNOVAR. They are using the second position (dbSNP) and i think this is good because doing that you only get those which have an SNP and not the indels because only in case of SNPs these positions are the same as the first...

        thanks again and regards,
        Karin

        Comment

        • kalinka23
          Junior Member
          • Aug 2011
          • 7

          #5
          output breakDancer

          Hi everybody,

          i have a question concerning the output of breakdancer: if i call variants with the commands:

          breakdancer-max1.2/bam2cfg.pl -g -h tumor.bam normal.bam > my.cfg
          breakdancer_max my.cfg > my.ctx

          the called variants are located in the tumor sample, right? I am confused and this is probably a very stupid question, but, in my output, i see for example the following:

          chr18 98582 22+1- chrY 11929053 25+2- CTX -214 99 21 normal.bam|21
          chr18 98981 2+7- chrY 11928187 1+5- CTX -214 99 5 normal.bam|5

          does this mean that the variants are located in the tumor sample based on (or compared to) the normal sample? And where can i find a manual to understand better all the output columns?

          Thanks a lot!

          Best, Karin

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 08-06-2026, 07:41 AM
          0 responses
          16 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 08-03-2026, 10:13 AM
          0 responses
          32 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          42 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          26 views
          0 reactions
          Last Post SEQadmin2  
          Working...